CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | Burnett Patrick | Grant or award | +28,000 | 85,032 | ||
| 2024-01-12 | Burnett Patrick | Grant or award · Stock Option (right to buy) | +276,000 | 276,000 | ||
| 2024-01-12 | Edwards Larry Todd Chief Commercial Officer | Grant or award | +28,000 | 88,000 | ||
| 2024-01-12 | Edwards Larry Todd Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +176,000 | 176,000 | ||
| 2024-01-12 | Matsuda Masaru | Grant or award | +28,000 | 74,634 | ||
| 2024-01-12 | Matsuda Masaru | Grant or award · Stock Option (right to buy) | +176,000 | 176,000 | ||
| 2024-01-12 | Watanabe Todd Franklin | Grant or award | +125,000 | 627,019 | ||
| 2024-01-12 | Watanabe Todd Franklin | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2024-01-12 | Moore Matthew Richard SVP and Chief Business Officer | Grant or award | +28,000 | 54,590 | ||
| 2024-01-12 | Moore Matthew Richard SVP and Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2024-01-02 | Burnett Patrick | Sale | −1,325 | $3.54 | $5K | 57,032 |
| 2023-12-20 | Watanabe Todd Franklin | Gift | −6,563 | 508,582 | ||
| 2023-12-20 | Watanabe Todd Franklin | Gift | −6,563 | 502,019 | ||
| 2023-12-20 | Watanabe Todd Franklin | Gift | +6,563 | 24,413 | ||
| 2023-12-20 | Watanabe Todd Franklin | Gift | +6,563 | 24,413 | ||
| 2023-12-01 | Watanabe Todd Franklin | Exercise or conversion | +59,525 | $1.68 | $100K | 513,682 |
| 2023-12-01 | Watanabe Todd Franklin | Exercise or conversion · Stock Option (right to buy) | −59,525 | 49,823 | ||
| 2023-11-21 | Matsuda Masaru | Sale | −1,850 | $1.98 | $4K | 46,634 |
| 2023-11-18 | Matsuda Masaru | Grant or award | +4,875 | 48,484 | ||
| 2023-10-24 | Frazier Life Sciences VIII, L.P. 10% owner | Purchase | +80,000 | $2.50 | $200K | 8,764,232 |
Page 22 of 35 · 689 trades